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Abstract
Background: Subclinical hypothyroidism (SH) is associated with adverse obstetric outcomes and neurodevelopment
disorders. Both iodine deficiency and excess are associated with SH; however, few data regarding iodine nutrition
status of pregnant women with SH are available. This study aimed to clarify whether iodine deficiency or excess is
associated with SH, especially, when test results for anti-thyroid autoantibodies are negative.
Methods: A total of 115 women with SH and 104 women with euthyroidism (EH) in early pregnancy in Tianjin, China
were investigated, and their serum thyroid-stimulating hormone, free thyroxine, free triiodothyronine, anti-thyroid
peroxidase antibody (TPOAb), anti-thyroid globulin antibody (TGAb), urinary iodine (UIC), and urinary creatinine (UCr)
concentrations were measured. Thyroid ultrasonography was performed to determine thyroid echogenicity and
volume. The UIC, UIC/UCr ratio, prevalence of TPOAb and TGAb positivity, and thyroid gland volume were compared
between the EH and SH groups. UIC and ultrasonographic features were analysed in subjects in the SH group who
were negative for TPOAb and TGAb.
Results: Median UIC of SH (154.0 μg/L) and EH (150.1 μg/L) met the World Health Organization criterion for iodine
sufficiency in pregnant women. Neither UIC nor the UIC/UCr ratio differed significantly between groups. The prevalence
of TPOAb and TGAb positivity in the SH group was significantly higher than that in the EH group (P < 0.01). The
percentage of subjects with UIC≥ 250 μg/L in the SH group was significantly higher than that in the EH group
(p = 0.004). The percentage of subjects negative for autoantibodies and UIC≥ 250 μg/L in the SH group tended to be
higher than that in subjects in the EH group negative for autoantibodies, but the difference was not statistically
significant (p = 0.025, adjusted test level α = 0.0167). Eight of 18 subjects in the SH group with negative results for TPOAb
and TGAb were diagnosed with Hashimoto thyroiditis by means of thyroid ultrasonography.
Conclusions: Women in early pregnancy with SH in Tianjin were iodine sufficient, but still at risk of iodine deficiency as
pregnancy progressed. UIC≥ 250 μg/L was associated with increased risk of SH. Serological negative autoimmune
thyroiditis and UIC≥ 250 μg/L may play a role in pathogenesis of SH cases with negative results for autoantibodies.
Keywords: Early pregnancy, Subclinical hypothyroidism, Urine iodine concentration, Anti-thyroid peroxidase antibody
(TPOAb), Anti-thyroid globulin antibody (TPOAb), Idiopathic subclinical hypothyroidism
* Correspondence: meichuqin@163.com
†Equal contributors
1Department of Endocrinology and Metabolism, Tianjin Medical University
General Hospital, No154 Anshan Road, Heping District, Tianjin 300052, China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wang et al. BMC Endocrine Disorders  (2017) 17:10 
DOI 10.1186/s12902-017-0162-x
Background
Hypothyroidism is a common comorbidity of pregnancy
and can be further categorised as clinical or subclinical
hypothyroidism (SH) according to reduced or normal
free thyroxine (FT4) levels. Clinical hypothyroidism can
result in retarded foetal growth, mental development
disorders, and adverse obstetric outcomes. Mounting
clinical evidence suggests that SH contributes to an in-
creased rate of obstetric complications and adverse birth
outcomes including gestational diabetes, gestational
hypertension, miscarriage, premature birth, small-for-
gestational-age babies, placental abruption, and postpar-
tum haemorrhage [1–4]. It is estimated that the preva-
lence of SH in pregnancy is 2.0–2.5% [5] worldwide and
4% [6] in China.
Iodine is the most important trace element for thyroid
hormone synthesis, and both iodine deficiency and iod-
ine excess are associated with SH [7, 8]. There was wide-
spread iodine deficiency in China until universal salt
iodisation in 1995. Since then, the prevalence of iodine
deficiency diseases has decreased remarkably, while the
prevalence of autoimmune thyroiditis and SH increased
[9]. Pregnant women are vulnerable to iodine deficiency,
and some cross-sectional surveys in different provinces
and areas of China have showed iodine deficiency in
pregnancy [10, 11]. However, few data regarding iodine
nutrition status in pregnant women with SH are avail-
able. An epidemic investigation in Tianjin, a northern
coastal city in China that is abundant in marine prod-
ucts, revealed iodine sufficiency [12]. To determine the
iodine nutrition status and the prevalence of positivity
for anti-thyroid peroxidase antibody (TPOAb) and anti-
thyroid globulin antibody (TGAb) in early pregnancy
with SH in Tianjin, this study evaluated the urinary iod-
ine concentration (UIC), TPOAb and TGAb positivity,
and ultrasonographic features of the thyroid gland in
early pregnancy in relation to SH, considering evidence
regarding iodine supplementation, anti-thyroid autoanti-
body screening, and proper intervention.
Methods
Subjects
Women in early pregnancy diagnosed as SH in the out-
patient clinic of the endocrinology department of Tianjin
Medical University General Hospital from September 2014
to October 2016 were included in the study. The control
group comprised those in early pregnancy diagnosed as
euthyroidism (EH) in the same hospital. Gestational age was
determined from foetal B mode ultrasonography and the
time of the last menstrual period. All subjects were local res-
idents and had lived in Tianjin more than 5 years. Women
with history of thyroid diseases or other comorbidities and
women who took thyroid medications, anti-thyroid drugs,
iodine-containing medications or supplements, or iodinated
contrast agents (e.g. amiodarone, cydiodine buccal tablets,
intravenous contrast agents, and iodine-containing nutrient
supplements) within the past 3 months were excluded from
the study.
The study was conducted in accordance with the prin-
ciples of good clinical practice and the Declaration of
Helsinki. The study protocol was approved by The Eth-
ics Committee of Tianjin Medical University General
Hospital, and written informed consent was obtained
from all participants.
Sample collection
Five millilitres fasting venous blood, without coagulation,
was drawn from all participants. Serum was separated
within 6 h and stored at −80 °C. Ten millilitres of fasting
urine were collected in specialised containers and stored
at −80 °C for testing UIC and urinary creatinine (UCr)
concentration.
Testing of thyroid function
Serum thyroid-stimulating hormone (TSH), free thyrox-
ine (FT4), free triiodothyronine (FT3), thyroid peroxidase
antibody (TPOAb), and thyroid globulin antibody
(TGAb) levels were all tested using a chemiluminescence
immunoassay test kit from Siemens, Germany. Quality
control was performed for all test kits. The intra- and
inter-assay coefficients of variation (n = 20) in our la-
boratory were, respectively, 2.7 and 4.6% for FT3, 3.2
and 4.9% for FT4, 2.6 and 4.6% for TSH, 7.2 and 11.2%
for TPOAb, and 7.9 and 12.3% for TGAb.
Testing of UIC and UCr
UIC was estimated using As3+-Ce4+ catalytic spectro-
photometry (WS/T-2006), a national method developed
by China’s Ministry of Health. To exclude the impact of
the volume and level of urine concentration on UIC,
UCr was tested along with urinary iodine, and the UIC/
UCr ratio was calculated.
Diagnostic criteria
All diagnoses were made according to specified refer-
ence values for gestational thyroid function as recom-
mended by the guidelines for the diagnosis and
treatment of gestational and postpartum thyroid diseases
in China proposed in 2012 [13]. Reference values for
TSH, FT4, TPOAb, and TGAb were 0.13–3.93 mIU/L,
12.00–23.34 pmol/L, 0–35 IU/L, and 0–20 IU/L, re-
spectively. Participants were divided into EH and sub-
clinical hypothyroidism (SH) groups according to TSH
and FT4 levels. Women with both normal TSH and FT4
were included in the former, while those with TSH levels
higher than the upper reference limit and normal FT4
values were included in the latter group.
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Gestational iodine nutritional standards
Iodine status was classified according to the World Health
Organization (WHO) criteria for pregnant women [14].
Median UIC of <20 μg/L, 20–50 μg/L, 51–149 μg/L, 150–
249 μg/L, 250–499 μg/L, and ≥500 μg/L corresponded to
severe, moderate, and mild iodine deficiency, and ad-
equate, more-than-adequate, and excessive iodine intake,
respectively.
Ultrasonography
Thyroid ultrasonography was performed by the same ex-
perienced physician using commercially available high-
definition colour-Doppler ultrasound equipment (HD11,
Philips Healthcare, Netherlands) equipped with a 7.5–12
MHz high frequency linear transducer. Patients were ex-
amined in a supine position with their neck hyperex-
tended in accordance with a standard sonographic
protocol. The volume of each lobe was calculated separ-
ately, using a formula for elliptical shape volume [(π/
6) × length × width × depth]. The thyroid volume was a
sum of the volumes of both lobes [15].
Statistical analysis
Data were analysed using SPSS 19.0 software (IBM, US).
Normally distributed data (age and gestational weeks)
were reported as mean ± standard deviation, and skewed
data (FT3, FT4, TSH, UIC, and UIC/UCr) were presented
as median and interquartile range (25th–75th percentiles).
Two independent-sample t-tests were used to compare
age and gestational weeks, and Wilcoxon rank sum tests
were used to compare FT3, FT4, TSH, UIC, and UIC/UCr
between the two groups. The chi-squared test or Fisher’s
exact test was adopted for frequency comparison. Spear-
man rank bivariate correlation was adopted for correlation
analysis. Two-tailed cut-offs were used, and a P value
<0.05 was considered statistically significant.
Results
Demographic features of patients
A total of 219 women in early pregnancy (average 10.1 ±
2.2 weeks) with an average age of 28.3 ± 3.1 years were en-
rolled in the study. One hundred four subjects in the EH
group were aged 28.0 ± 3.0 years and had gestated for
10.1 ± 2.3 weeks, while 115 subjects in the SH group were
aged 28.6 ± 3.2 years and had gestated for 10.2 ± 2.0 weeks.
There were no significant differences between age and
gestational week between the two groups (Table 1).
Iodine nutritional status in early pregnancy with SH in Tianjin
The median (range) UIC in the SH and EH groups was
154.0(93.1–243.1) μg/L and 150.1(103.5–187.5) μg/L, re-
spectively, with no significant difference between the
groups (Z = −1.198, p = 0.231). The median UIC/UCr ra-
tio in the SH and EH groups was 140.7(98.1–226.4) μg/g
and 131.7(82.8–183.9) μg/g, respectively, and was not
significantly different between the groups (Z = −1.465, p
= 0.143) (Table 1). Among those in the SH group, the
distribution by UIC ≤ 50 μg/L, 51–149 μg/L, 150–
249 μg/L and ≥250 μg/L levels were 6.0, 43.5, 26.2, and
24.3%, respectively, while those in the EH group were
5.8, 43.3, 41.3, and 9.6% respectively. There was a signifi-
cant difference in the percent distributions between the
two groups (χ2 = 10.656, p = 0.014). The percentage of
those with UIC ≥ 250 μg/L in the SH group was signifi-
cantly higher than that in the EH group (χ2 = 8.265, p =
0.004) (Table 2, Fig. 1).
Prevalence of TPOAb and TGAb and its relationship with
thyroid function
The prevalence of TPOAb and TGAb in the SH group
was significantly higher than that in the EH group
(79.1% vs 56.7%, χ2 = 12.697, p = 0.000 for TPOAb and
69.6% vs 40.4%, χ2 = 18.847, p = 0.000 for TGAb). FT4
level in the SH group was significantly lower than that
in the EH group (Z = −3.157, p = 0.002), however FT3
and thyroid volume did not differ significantly between
the two groups. There was no significant relationship be-
tween TSH or FT4 and TPOAb level in women in early
pregnancy (p > 0.05).
UIC and ultrasonographic features of subjects in the SH
group with negative TPOAb and TGAb
Among subjects in the SH group, 15.7% were negative
for both TPOAb and TGAb. In the SH group, there were
no significant differences in TSH and FT4 between the
autoantibody-negative and -positive subgroups (p =
0.706 for TSH and p = 0.122 for FT4). To explore the
possible aetiology of SH in subjects with negative anti-
thyroid autoantibodies, we analysed UIC and ultrasono-
graphic features of the subjects. The distribution fre-
quencies in the autoantibody-negative SH group among
those with UIC < 150 μg/L, 150–249 μg/L and ≥250 μg/
L were 38.9% (7/18), 33.3% (6/18), and 27.8% (5/18), re-
spectively, while those in the autoantibody-negative EH
group were 50.0% (20/40), 45.0% (18/40), and 5.0% (2/
40), respectively. The distribution frequencies tended to
be different between the two groups, but the difference
was not statistically significant (p = 0.066) (Table 3). The
percentage of those with more-than-adequate and exces-
sive iodine in the autoantibody-negative SH group
tended to be higher than that in the autoantibody-
negative EH group, but the difference was not statisti-
cally significant (p = 0.025, adjusted test level α = 0.0167)
(Table 3). In the autoantibody-negative SH group, eight
of 18 presented as diffuse hypoechoic and heterogeneous
echo texture by ultrasonography, and were thereby diag-
nosed as Hashimoto thyroiditis.
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The relationship between UIC and thyroid function in
early pregnancy
UIC was not significantly correlated with FT3, FT4, and
TSH levels in early pregnancy (p > 0.05).
Discussion
Demand for iodine as a nutrient increases in pregnancy
to support a series of physiological changes [16, 17], in-
cluding increased iodine clearance as a consequence of
increased renal blood flow and glomerular filtration,
transplacental iodine transfer from mother to foetus, in-
creased demand for thyroid hormone due to maternal
hormone transplacental transfer to foetus, and increased
combined thyroid hormone due to increased thyroid
hormone-binding globulin production in response to
higher oestrogen levels. Severe iodine deficiency in preg-
nancy can lead to maternal hypothyroidism, impairing
neurological development of the foetus [18]. Moreover,
even mild and moderate iodine deficiency in early preg-
nancy can impair the final intelligence and scholastic
ability of progeny [19, 20]. On the other hand, excessive
iodine intake may be detrimental to pregnant women
and increase their risk for developing hypothyroidism
and autoimmune thyroiditis [21]. Investigations such as
the current study that investigate iodine nutrition status
in women with SH in early pregnancy may help to pro-
vide a basis for proper iodine intake guide.
As >90% of ingested iodine is ultimately excreted in the
urine, UIC is a good indicator of iodine nutritional status,
and median UIC from a large sample in a previous study
has been widely used as a biomarker of population iodine
intake [22]. WHO recommends an optimum median UIC
of 150–249 μg/L for pregnant women [14]. In the current
study, median UIC in early pregnant women with subclin-
ical hypothyroidism and euthyroidism was 154.0(93.1–
243.1) and 150.1(103.5–187.5) μg/L, respectively, both of
which are at the lower limit of the iodine sufficiency range.
In contrast, results of iodine nutrition status surveys in
different geographical regions of China have produced dis-
parate results. In Henan province, an inland area, median
UIC in pregnancy was 198 μg/L, and the iodine nutrition
was adequate [23], while in Zhejiang province, a coastal
area, median UIC in pregnancy was 130 μg/L, and the iod-
ine nutrition was deficient [11]. In Shijiazhuang province,
median UIC declined as gestational age increased, and the
iodine nutrition status shifted from iodine sufficiency in
the first trimester to deficiency in the second and third tri-
mesters of pregnancy [24]. The present study showed that
iodine nutrition status in early pregnancy in Tianjin was
adequate, but that median UIC was at the lower limit; in
Table 2 Comparison of urinary iodine concentration (UIC)
frequency distribution between the euthyroidism and
subclinical hypothyroidism groups
Group UIC (μg/L) frequency distribution Total
≤50 51–149 150–249 ≥250
Euthyroidism 6 45 43 10 104
Subclinical hypothyroidism 7 50 30 28 115
Total 13 95 73 38 219
P 0.921 0.975 0.017 0.004 0.014
Fig. 1 Urinary iodine concentration (UIC) distribution among early pregnant women with euthyroidism and subclinical hypothyroidism in Tianjin. The
percentage distribution was significantly different between the euthyroidism (EH) and subclinical hypothyroidism (SH) groups (χ2 = 10.656, p = 0.014).
The percentage of those with UIC≥ 250 μg/L in the SH group was significantly higher than that in the EH group (χ2 = 8.265, p = 0.004)
Table 3 Comparison of urinary iodine concentration (UIC)
frequency distribution between the euthyroidism and
subclinical hypothyroidism groups with negative anti-thyroid
autoantibodies
Group UIC (μg/L) frequency distribution Total
<150 150–249 ≥250
Euthyroidism 20 18 2 40
Subclinical hypothyroidism 7 6 5 18
Total 27 24 7 58
P 0.433 0.404 0.025 0.066
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addition, at mid-gestation, the foetal thyroid gland begins
to produce thyroid hormone, leading to transplacental
iodine transfer, further exacerbating iodine deprivation of
the mother; accordingly, pregnant women in Tianjin are
likely still at risk of iodine deficiency as the pregnancy pro-
gresses. According to WHO, pregnant women should
have an iodine intake of at least 250 μg daily [14]. Since
the iodine content of edible salt in Tianjin is 30 mg/kg
(permitted range ±30%) [25] and the average salt con-
sumption is inadequate at 6 g/d (the average reported
consumption), pregnant women in Tianjin require add-
itional iodine intake from other sources.
The current study showed that the percentage of those
with more-than-adequate and excessive iodine in the SH
group was significantly higher than that in the EH
group. These findings indicate that iodine excess, rather
than iodine deficiency, is associated with SH in early
pregnancy in Tianjin. In most cases, excessive iodine in-
take may inhibit thyroid hormone synthesis and secre-
tion to protect the body from thyrotoxicosis, the so-
called acute Wolff-Chaikoff effect [26], which is typically
transient and lasts only 24–48 h. However, some vulner-
able individuals with underlying thyroid abnormalities
might fail to escape from the Wolff-Chaikoff effect,
resulting in iodine-induced hypothyroidism [27]. Sec-
ondly, iodine excess itself can trigger autoimmune thy-
roiditis in some genetically susceptible individuals and
lead to hypothyroidism. A study conducted by Sang
et al. revealed that excessive iodine intake during late
pregnancy might lead to maternal thyroid dysfunction,
particularly SH [21]. A cross-sectional study of 7190
women in early pregnancy in China also showed that
UIC ≥ 250 μg/L is associated with a significantly high
risk of SH and that UIC ≥ 500 μg/L is associated with a
high risk of isolated hypothyroxinemia [8]. Therefore,
pregnant women with SH should be instructed to con-
sume an appropriate amount of iodine to avoid excessive
iodine intake.
The prevalence of TPOAb (79.1%) and TGAb (69.6%)
positivity in early pregnancy with SH was significantly
higher than that in subjects with euthyroidism, suggest-
ing that autoimmune thyroiditis is the major cause of
SH in early pregnancy in Tianjin. Additionally, TPOAb
and TGAb positivity is a risk factor for postpartum thy-
roiditis [28] and thus deserves particular attention in
pregnant women.
Although 15.7% of subjects in the SH group were both
TPOAb- and TGAb-negative, the serum TSH and FT4 level
was not significantly different between the autoantibody-
negative and -positive subgroups. Eight of 18 subjects in
the SH group with negative thyroid antibodies were diag-
nosed as autoimmune thyroiditis by means of thyroid ultra-
sonography. Rago has confirmed the value of thyroid
ultrasonography in detecting autoimmune thyroiditis in
cases with negative thyroid antibodies [29]. Therefore, SH
with negative anti-thyroid autoantibodies in early preg-
nancy in the present study might partly be attributable to
serological negative autoimmune thyroiditis. Moreover,
there tended to be a greater percentage of those with more-
than-adequate and excessive iodine in the autoantibody-
negative SH group than that in the autoantibody-negative
EH group, therefore more-than-adequate and excessive iod-
ine, rather than iodine deficiency, might be associated with
SH in those with negative thyroid autoantibodies. However
due to the small sample size, these findings need to be fur-
ther investigated.
There were remaining ten subjects both negative for
thyroid antibodies and ultrasonography, in the literature,
such cases are referred to as “idiopathic subclinical
hypothyroidism” [30] or “non-autoimmune subclinical
hypothyroidism” [31]. Recently, idiopathic SH was re-
ported to be associated with TSH resistance due to TSH
receptor mutations [31]. Furthermore, obesity and over-
weight are related to elevated TSH level [32], but the
contribution of elevated TSH level to SH in pregnancy
remains unclear and needs to be investigated.
There are some limitations in our study. Firstly, the in-
cidence of SH in pregnancy has been reported to be 2–
4% [6], and some pregnant women do not undergo thy-
roid function screening in early pregnancy. To achieve a
sample size of approximately 100, we screened 4600
women in early pregnancy, thus there was a small sam-
ple size. Secondly, the spot UIC used to assess iodine
nutrition status of the subjects only reflects recent iod-
ine intake and varies according to extent of hydration,
thus limiting its usefulness as a screening tool.
Conclusions
In summary, the current results show that women with SH
in early pregnancy in Tianjin were iodine sufficient, but
remained at risk of iodine deficiency as pregnancy pro-
gressed. Moreover, more-than-adequate and excess iodine
(UIC ≥ 250 μg/L) were associated with SH. In addition,
serological negative autoimmune thyroiditis and UIC ≥
250 μg/L may play a role in pathogenesis of SH with nega-
tive autoantibodies. However, owing to the small sample
size and limited usefulness of spot UIC, a larger sample
study is needed to confirm the results.
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